NTRK1 fusion in glioblastoma multiforme.

NTRK1 fusion in glioblastoma multiforme.

Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor, yet with no targeted therapy with substantial survival benefit. Recent studies on solid tumors showed that fusion genes often play driver roles and are promising targets for pharmaceutical intervention. To survey potential fus...

Full description

Bibliographic Details
Main Authors: Jinkuk Kim, Yeri Lee, Hee Jin Cho, Young-Eun Lee, Jaeyeol An, Gye-Hyun Cho, Young-Hyeh Ko, Kyeung Min Joo, Do-Hyun Nam
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3960150?pdf=render

Internet

http://europepmc.org/articles/PMC3960150?pdf=render

Similar Items